For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Market Overview of Global Albendazole for Veterinary Use market:
According to our latest research, the global Albendazole for Veterinary Use market looks promising in the next 5 years. As of 2022, the global Albendazole for Veterinary Use market was estimated at USD 162.64 million, and it's anticipated to reach USD 245.61 million in 2028, with a CAGR of 7.11% during the forecast years.
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. Albendazole primarily exerts its therapeutic efficacy by exerting its inhibitory effect on tubulin polymerization which eventually results in the loss of cytoplasmic microtubules. It causes the depletion of energy production of the parasite causing immobilization and death of the parasite. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hindering the production of ATP, and makes the parasite unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes the death of the worm.
Strengths
Zoetis has a strong base of reliable supplier of raw material thus enabling the company to overcome any supply chain bottlenecks.
Strong distribution network - Over the years Zoetis has built a reliable distribution network that can reach majority of its potential market.
Weaknesses
The company has not been able to tackle the challenges present by the new entrants in the segment and has lost small market share in the niche categories.
There are gaps in the product range sold by the company. This lack of choice can give a new competitor a foothold in the market.
Opportunities
New customers from online channel - Over the past few years the company has invested vast sum of money into the online platform. This investment has opened new sales channel for Zoetis.
The diminishing boundaries and rising global interconnectedness allow the organisation to get into the international market; target geographically dispersed customer base and increased profitability.
Threats
The changing regulatory framework and introduction of new stricter regulations impose a major threat to the Zoetis Inc. It makes compliance with legal standards more complex and challenging for the business organisation. Inability to comply with changed regulations raises the risk of expensive law suits.
Imitation of the counterfeit and low quality product is also a threat to Zoetis's product especially in the emerging markets and low income markets.
Region Overview:
From 2023-2028, United States is estimated to witness robust growth prospects.
Company Overview:
The top three companies are Zoetis, Ceva Santé Animale, Virbac with the revenue market share of 26.84%, 7.88%, 6.47% in 2022.
Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. Building on more than 65 years of experience, Zoetis delivers quality medicines, vaccines and diagnostic products, complemented by biodevices, genetic tests and precision livestock farming. Zoetis is working every day to better understand and address the real-world challenges faced by those who raise and care for animals in ways they find truly relevant.
Ceva Santé Animale (Ceva) is a multinational animal health company based in Libourne, France. Established in 1999, Ceva undertakes research, development, production and marketing of pharmaceutical products and vaccines, and also provides complementary services and equipment, for companion animals, poultry, ruminants and swine. Ceva also supplies; hatchery vaccines, vaccination services and equipment; pheromone-based behavioural products for cats and dogs with additional knowledge in companion animal cardiology, locomotion and dermatology; products for the management of reproduction in ruminants such as antibiotic therapies and vaccines; and a growing range of products for swine, including antibiotic therapies, reproduction management and vaccines.
Segmentation Overview:
Among different product types, Albendazole 10% segment is anticipated to contribute the largest market share in 2028.
Application Overview:
By application, the Farm Animals segment occupied the biggest share from 2018 to 2022.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Albendazole for Veterinary Use market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.
Key Takeaways from the Global Albendazole for Veterinary Use Market Report:
Market Size Estimates: Albendazole for Veterinary Use market size estimation in terms of value and sales volume from 2018-2028
Market Trends and Dynamics: Albendazole for Veterinary Use market drivers, opportunities, challenges, and risks
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Albendazole for Veterinary Use market
Segment Market Analysis: Albendazole for Veterinary Use market value and sales volume by type and by application from 2018-2028
Regional Market Analysis: Albendazole for Veterinary Use market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa
Country-level Studies on the Albendazole for Veterinary Use Market: Revenue and sales volume of major countries in each region
Albendazole for Veterinary Use Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.
Trade Flow: Import and export volume of the Albendazole for Veterinary Use market in major regions.
Albendazole for Veterinary Use Industry Value Chain: Albendazole for Veterinary Use market raw materials & suppliers, manufacturing process, distributors, downstream customers
Albendazole for Veterinary Use Industry News, Policies & Regulations
Key players in the global Albendazole for Veterinary Use market are covered in Chapter 12:
Zoetis
Mankind Pharma
Veyong
Interchemie
Jinhe Biotechnology
Kangmu
Ceva Santé Animale
Bimeda
Chanelle Pharma
Virbac
In Chapter 2 and Chapter 15.1, based on types, the Albendazole for Veterinary Use market from 2018 to 2028 is primarily split into:
Albendazole 2.5%
Albendazole 10%
Others
In Chapter 3 and Chapter 15.2, based on applications, the Albendazole for Veterinary Use market from 2018 to 2028 covers:
Farm Animals
Pet Animals
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:
North America (Covered in Chapter 7)
United States
Canada
Asia-Pacific (Covered in Chapter 8)
China
Japan
India
South Korea
Southeast Asia
Australia
Others
Europe (Covered in Chapter 9)
Germany
France
UK
Italy
Spain
Russia
Poland
Others
Latin America (Covered in Chapter 10)
Mexico
Brazil
Argentina
Others
Middle East and Africa (Covered in Chapter 11)
GCC Countries
Africa
Others
The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.
In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.
Chapter Outline
This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 starts the report with an overview of the Albendazole for Veterinary Use market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.
Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.
Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.
Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.
Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.
Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.
Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.
Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.
Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.
Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.
Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028